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Regular physical activity is a cornerstone in the prevention
and treatment of atherosclerotic cardiovascular disease
(CVD) due to its positive effects in reducing several
cardiovascular risk factors. Current guidelines on CVD
suggest for healthy adults to perform at least 150 min/week
of moderate intensity or 75 min/week of vigorous intensity
aerobic physical activity. The current review explores the
effects of physical activity on some risk factors, specifically:
diabetes, dyslipidemia, hypertension and hyperuricemia.
Physical activity induces an improvement in insulin
sensitivity and in glucose control independently of weight
loss, which may further contribute to ameliorate both
diabetes-associated defects. The benefits of adherence to
physical activity have recently proven to extend beyond
surrogate markers of metabolic syndrome and diabetes by
reducing hard endpoints such as mortality. In recent years,
obesity has greatly increased in all countries. Weight losses
in these patients have been associated with improvements
in many cardiometabolic risk factors. Strategies against
obesity included caloric restriction, however greater results
have been obtained with association of diet and physical
activity. Similarly, the beneficial effect of training on blood
pressure via its action on sympathetic activity and on other
factors such as improvement of endothelial function and
reduction of oxidative stress can have played a role in
preventing hypertension development in active subjects.
The main international guidelines on prevention of CVD
suggest to encourage and to increase physical activity to
improve lipid pattern, hypertension and others
cardiovascular risk factor. An active action is required to the
National Society of Cardiology together with the Italian
Society of Sports Cardiology to improve the prescription of
organized physical activity in patients with CVD and/or
cardiovascular risk factors.
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Introduction
Physical activity is defined as any body movement that
increases oxygen consumption and can be performed
during work or during leisure activities. On the contrary
exercise is defined as the physical activity that improves
health or gains performance benefits.1
Several studies demonstrated that regular physical activ-
ity reduces rates of all-cause mortality, cardiovascular
disease (CVD), hypertension, stroke, metabolic syn-
drome, type 2 diabetes (T2D) as well as of other chronic
medical conditions.2 Regular physical activity is a corner-
stone in the prevention and treatment of atherosclerotic
CVD due to its positive effects in reducing SBP/DBP,
body weight, blood glucose, triglycerides, LDL choles-
terol (LDL-C) and in improving HDL cholesterol
(HDL-C).1 Conversely, according to the WHO, physical
inactivity is the fourth leading risk factor for global
mortality and its prevalence can be compared with all
other cardiovascular risk factors; consequently exercise
and regular physical activity are recommended for both
primary and secondary prevention of CVD2–4 (Table 1).
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Current guidelines on CVD suggest for healthy adults of
all ages to perform at least 150 min/week of moderate
intensity or 75 min/week of vigorous intensity aerobic
physical activity or an equivalent combination thereof; for
additional benefits in healthy adults, a gradual increase in
aerobic physical activity to 300 min/week of moderate
intensity, or 150 min/week of vigorous intensity aerobic
physical activity, or an equivalent combination thereof is
recommended.4 The aim of this review is to analyse the
effects of regular physical activity and exercise on the
main cardiovascular risk factors and to discuss the main
mechanisms involved.
The dose of physical activity ‘something is
better than nothing’
As mentioned before current international guidelines
generally recommend 150 min/week of moderate to vig-
orous physical activity.4,5 Despite several studies were
conducted in the attempt to assess the minimal and
optimal dosage of physical activity, this still remains an
open issue. Wen et al.6 demonstrated that even a lower
amount of exercise (15 min a day or 90 min a week of
moderate-intensity exercise) than the recommended
150 min a week could result in healthy benefits irrespec-
tive of age, sex and CVD risk. Nevertheless the lower and
upper limit of aerobic physical activity intensity, duration
and frequency to exert a beneficial effect are still
unknown.6,7 In fact, despite the proven benefits of phys-
ical activity, extreme exercise may increase risk of car-
diovascular events although this matter remains
controversial and the risk of an adverse cardiovascular
response during physical activity is really negligible in
healthy adults.6,7
Effects of physical activity on endothelial
dysfunction
The onset of CVDs is mediated by vascular damage that
lead to atherogenesis and plaque formation.8 One of the
most important and earliest events that prime vascular
damages is the impairment of the endothelium caused by
an excess of stimuli or by a failure of an endothelial
repair.9 As a consequence, its antithrombotic properties
are affected, promoting typical pathological changes
observed in atherosclerotic CVD.10 The damage to endo-
thelial cells can be caused by an overcoming of the
defence mechanisms of the endothelium,11 including
mechanical stretch due to high blood pressure (BP),
metabolites such as reactive oxygen species or innate
immune activation.12 Several conditions have been iden-
tified as risk factors for endothelial dysfunction: hyper-
tension, hyperlipidaemia, diabetes, cigarette smoke,
homocysteinaemia, ageing and low levels of physical
activity13 Moreover, endothelial dysfunction represents
an independent predictor for cardiovascular events,
besides the traditional risk factors.14
Endothelial cells have a role in several mechanisms by
regulating vasodilation, vasoconstriction, haemostasis,
growth of vascular smooth muscle cells (VSMC), interac-
tion between leukocytes and inflammation.15 Endothe-
lium can be damaged by increased vasoconstriction,
platelet aggregation and adhesion leading to a prothrom-
botic state, by an increased smooth muscle proliferation
and vascular inflammation.15 Nitric oxide (NO) is one of
the most important endogenous vasodilators produced by
endothelial cells having a role in the inhibition of the
aggregation of platelets, oxidative stress, VSMCs, recruit-
ing of leukocytes and leukocyte adhesion.16 Its deficien-
cies may be the first manifestation of endothelial
dysfunction13 in the absence of modifications in the
structure of the vessel wall.17
NO reduction is a consequence of oxidative stress in the
endothelial cells that is associated with an increased risk
of endothelial dysfunction18 and to inflammation that
alters the capacity of vessels to respond to endothe-
lium-dependent vasodilators and vasoconstrictors.18
Product from damaged endothelial cells and oxidative
stress activate NLRP3 inflammasome, a multiproteic
complex that mediates the proteolytic cleavage of proin-
flammatory IL-1b and IL-18.19 Finally, these modifica-
tions are exacerbated by inflammaging, an age-related
condition characterized by a persistent inflammation, that
carries high susceptibility to comorbidities and death20
and that can overlap with other inflammatory pathologies
or favour their onset, as in the case of CVD21,22 (Fig. 1).
Physical activity exerts different effects in the cardiovas-
cular system, including the increase of cardiac output and
the decrease of peripheral vascular resistance.23,24 In fact,
physical activity can provoke a unidirectional shear force
in vessels, determining an increase of NO production by
endothelial cells.25 NO-dependent vasodilation favours
tissue perfusion and antiatherogenic effects highlighting
the beneficial effects of physical activity on a cardiovas-
cular system by improving the endothelium function and,
as a consequence, the reduction of inflammation.
Effects of physical activity on obesity and
weight loss
Over recent decades, obesity has greatly increased in all
countries. In the USA, it has been projected that if
obesity trends from 2005 to 2020 continue, obesity will
increasingly offset the positive effects of declining smok-
ing rates.4
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Table 1 Benefits of physical activity on cardiovascular risk factors
Reduced cardiovascular mortality
Reduced incidence of cardiovascular disease
Reduced blood pressure
Combined with diet-induced weight loss
Reduced incidence of type 2 diabetes
Improved lipid profile
Modulated the serum uric acid–hypertension relationship
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Obesity is a major risk factor for many CVDs such as
coronary heart disease (CHD), heat failure, stroke, ven-
tricular dysfunction and cardiac arrhythmias.4 The Amer-
ican Heart Association’s scientific statement on obesity
and weight loss recommends weight loss in overweight
and obese patients to reduce the severity of cardiovascu-
lar risk factors. Weight loss in these patients has been
associated with improvements in many cardiometabolic
risk factors such as prevalence of the metabolic syn-
drome, insulin resistance, type 2 diabetes mellitus
(T2DM), dyslipidaemia, hypertension, pulmonary dis-
ease, CVD and inflammation.26 Changes in weight are
influenced by the amount of energy expended versus that
consumed. Therefore, if the energy expenditure remains
low, but dietary consumption levels are in excess, weight
gain will occur. Several researchers have argued that
declines in physical activity both in occupational and
leisure time may play an important role in the increase
in obesity rates over the last 30þ years.27 Furthermore,
many epidemiological studies suggest that physical activ-
ity has an important role in weight gain.28 An important
question is if there is a difference between weight losses,
achieved through dietary means, or through ET in terms
of cardiovascular risk factors. Ross et al. randomized a
group of obese men (n¼ 52) to diet-induced weight loss,
exercise-induced weight loss, exercise without weight
loss and a control group for 3 months. The diet-induced
and exercise-induced weight loss groups lost approxi-
mately 7 kg of weight (8% weight reduction), and had
significant reductions in total fat mass, visceral fat and
increased glucose disposal. However, the ET-induced
weight loss group had a greater reduction in total fat mass
compared with the diet-induced weight loss group.
Importantly, the exercise-induced weight loss improved
cardiorespiratory parameters whereas the dietary group
did not. In the group who performed ET without weight
loss, the participants still experienced reductions in vis-
ceral fat and improved cardiorespiratory parameters.29
Recent epidemiological evidence has emerged showing
greater survival in adults with CVDs with higher obesity
levels compared with lower levels, which has been coined
‘the obesity paradox’.30 Systematic reviews of patients
with CAD or undergoing percutaneous coronary inter-
vention supported the ‘obesity paradox’ whereby obesity
appears protective.31 Cardiorespiratory fitness might
influence relationships between adiposity and clinical
prognosis in the obesity paradox. Normal weight unfit
individuals have a higher risk of mortality than fit indi-
viduals, regardless of their BMI.4
Furthermore, the results of the European Prospective
Investigation into Cancer and Nutrition (EPIC) study
suggest that the influence of physical inactivity on mor-
tality appears to be greater than that of high BMI.32 CVD
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risk has a continuous positive relationship with BMI and
other measures of body fat. Because all-cause mortality
appears to increase at BMI levels, European Society of
Cardiology guidelines recommend such low BMI levels
as treatment goals. Although diet, exercise and behaviour
modifications are the mainstay therapies for overweight
and obesity, however they are often unsuccessful for
long-term treatment.
Results from the EPIC study suggested that the most
pronounced risk reductions by increasing levels of physi-
cal activity were observed in those categorized as normal
weight and abdominally lean. However, across all strata
for both general and abdominal adiposity, a markedly
reduced hazard was observed between those categorized
as inactive or as moderately inactive. Similarly, data from
the United States suggest that physical activity reduces
but does not eliminate the increased risk of adiposity on
all-cause mortality when cross-classifying activity and
BMI groups.33,34
In an Asian population a protocol of exercising for 15 min/
day (defined as the low-volume exercise group) is associ-
ated with a 14% reduction in risk of all-cause mortality
compared with inactivity.6 EPIC study extend these
observations to European men and women and suggest
that, within each strata for BMI and WC, the hazard of all-
cause mortality was substantially reduced when the inac-
tive group was compared with the moderately inactive
group. Thus, emerging evidence is accumulating indicat-
ing that substantial health benefits may be achieved by
fairly small increases in physical activity.
Effects of physical activity on diabetes
T2D estimates have reached pandemic proportions 
327 million in subjects aged 20–64 years worldwide.35
The presence of diabetes mellitus is associated with a
mortality rate of 1.5%/year which is doubled compared
with age-matched controls, with CVD being the primary
complication and the leading cause of death in these
patients.36 Lifestyle modification, including physical
activity, is the core therapy in all stages of diabetes
mellitus.37
Indeed, physical activity induces an improvement in
insulin sensitivity and in glucose control independently
of weight loss, which may further contribute to ameliorate
both diabetes-associated defects.38,39 A central role in
exercise-mediated metabolic changes and in increased
contraction-stimulated glucose uptake (via glucose trans-
porter GLUT4 in the sarcolemma and T tubules) is
played by adenosine monophosphate (AMP)-activated
protein kinase (AMPK), a protein that acts as the energy
gauge in the body sensing AMP levels. AMPK-mediated
effects have been well described; briefly AMPK activa-
tion increases free fatty acid (FFA) oxidation in the liver
and muscle, inhibits cholesterol synthesis in the liver and
decreases gluconeogenesis and promotes muscle glucose
uptake. Another key mechanism to elucidate beneficial
effects of physical activity is due to the induced release in
myokines from the skeletal muscle, which mediates the
crosstalk with adipose tissue, liver, pancreas, bone and
brain. Specifically, myokines such as irisin, IL-6, coun-
teract the secretion of proinflammatory adipokines (i.e.
resistin, TNF-a, MCP-1) protecting against chronic sys-
temic low-grade inflammation. In addition, irisin regu-
lates liver glycogenesis and gluconeogenesis, and several
myokines regulate lipolysis and FFA oxidation in adipo-
cytes (IL-6, IL-15, irisin, myostatin).40 More recently, it
has been shown that physical activity is associated with a
reduced risk of having significant CAC in individuals with
metabolic syndrome.41
In conclusion, while still very much underutilized, fitness
should be taken into consideration in everyday clinical
risk prediction in addition to the traditional risk factors of
the metabolic syndrome and diabetes mellitus.
Interrupting prolonged sitting with 3-min bouts or with
light-intensity walking or simple resistance activities
(half-squats, calf raises, gluteal contractions and knee
raises) every 30 min attenuates acute postprandial glu-
cose, insulin, C-peptide and triglyceride responses in
T2D.42
These results have been acknowledged in the American
Diabetes Association 2018 guidelines which recommend
that individuals with diabetes should reduce their seden-
tary time by breaking up prolonged bouts of sitting with
light activity for a few minutes at least every 30 min.37
The benefits of adherence to physical activity have
recently proven to extend beyond surrogate markers of
diabetes mellitus late complications (i.e. glucose or A1C)
by reducing hard endpoints such as mortality.
Greater adherence to an overall healthy lifestyle defined
as eating a high-quality diet, nonsmoking, engaging in
moderate to vigorous intensity physical activity, and
drinking alcohol in moderation is associated with a sub-
stantially lower risk of CVD incidence (52%) and mor-
tality (68%) among adults with T2D.32 Similarly,
sedentary time has been shown to increase the risk
of all-cause mortality [HR, 1.240 (95% confidence
interval {CI}, 1.090–1.410)], CVD mortality [HR, 1.179
(CI, 1.106–1.257)] and CVD incidence [HR, 1.143 (CI,
1.002–1.729)].43
A few other aspects need consideration. Although there is
a robust effect of exercise on insulin sensitivity, a high
variability exists in terms of interindividual glycaemic
response following physical activity.44 Pancreatic b-cell
function is a stronger predictor of changes in glycaemic
control after an aerobic exercise intervention than insulin
sensitivity.44 In a ‘real world’ setting this heterogeneity
may simply depend on exercise dose, type, meal timing,
drug timing, but also on exercise adherence or exposure
to a hyperglycaemic milieu. However, it cannot be
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excluded that genetic/epigenetic modifications may
account for a reduced/lack of glycaemic response to physi-
cal activity.45 Despite these limitations and the possible
barriers due to an increased risk of hypoglycaemia occur-
rence, physical activity in diabetes mellitus should always
be encouraged as a key aspect to diabetes mellitus therapy,
as also recognized by all International Guidelines.37
Pedometer data were obtained on 7118 participants and
35.0% developed diabetes. In an unadjusted analysis
each 2000-step increment in the average number of daily
steps, up to 10 000, was associated with a 5.5% lower risk
of progression to diabetes (HR 0.95, 95% CI 0.92–0.97),
with more than 6% relative risk reduction after adjust-
ment.46
There is some evidence from RCTs that exercise per-
formed 30 min after meal consumption may convey
greater improvements in glycaemic control for individu-
als with T2DM. However, there are only two studies that
have directly assessed the role of exercise timing on
glycaemic management and adopted methodologies are
heterogeneous.47
Compared with either supervised aerobic or supervised
resistance exercise alone, combined exercise showed
more pronounced improvement in HbA1c levels; how-
ever, there was a less marked improvement in some
cardiovascular risk factors. In terms of weight loss, there
were no significant differences among the combined,
supervised aerobic and supervised resistance exercises.48
Effects of physical activity on lipids
Dyslipidaemia represent one of the strongest indepen-
dent risk factors for CVD. Among lipoprotein disorders
the most strongly related to CVD risk is the plasma level
of LDL-C. Other quantitative lipid risk factors are high
level of total cholesterol, non-HDL-C, triglycerides
(especially if postprandial), apolipoprotein B and Lipo-
protein (a). Qualitative risk factors are oxidized LDLs
and small dense LDLs. Conversely, plasma HDL-C
levels are in some way protective against CVDs.49
Although the mechanism of exercise-induced lipid
changes is unclear, exercise itself may affect lipid metab-
olism in several ways. In particular, physical exercise
could increase endothelial lipoprotein-lipase activity,
thus increasing chylomicrons and VLDL triglycerides
hydrolysis in granules. Aerobic exercise may also increase
the expression of ATP-binding cassette transporter A-1
(ABCA1) thus improving reverse cholesterol transport
and HDL-C formation and increase the expression of
the Liver X receptor, also improving the ABCA1 expres-
sion. Finally, exercise could also reduce the serum level
of proprotein convertase subtilisin/kexin type nine thus
promoting the removal of LDL-C from plasma by the
liver50 (Fig. 1 Supplemental material, http://links.lww.
com/JCM/A192).
The main international guidelines suggest fighting
against sedentary behaviour and increasing physical
activity to improve the lipid pattern.51 How is it sup-
ported by the scientific literature? Physical activity per se
does not seem to significantly improve lipid profiles in
children, except for a mild irrelevant lowering effect on
triglycerides.52
On the other hand, concurrent aerobic and resistance
exercise training led to a significant reduction of LDL-C
level (MD¼10.20 mg/dl), even higher in long-term
programmes (>24 weeks).53 Walking per se could not
have any effect on lipid parameters. However, a mild
improvement of LDL-C levels could be observed with
longer persistence, and that of triglycerides with longer
sessions.54
A recent large meta-analysis of randomized clinical trials
testing the metabolic effect of structured physical exer-
cise (not simply physical activity) showed that exercise
training significantly lowered the levels of triglycerides
(P¼ 0.02) and increased the levels of HDL-C (P< 0.001)
and apolipoprotein A1 (P< 0.001). The WMDs were
5.31 mg/dl (95% CI 10.63 to 0.89; I2¼ 71.8%;
P< 0.001 for heterogeneity) for triglycerides, 2.32 mg/
dl (95% CI 1.16–3.87; I2¼ 87.5%; P< 0.001 for hetero-
geneity) for HDL-C, and 0.03 g/l (95% CI 0.02–0.04;
I2¼ 0.0%; P¼ 0.81 for heterogeneity) for apolipoprotein
A1. No changes were observed with respect to TC, LDL-
C, VLDL-Cholesterol, apolipoprotein B and FFAs. From
a clinical point of view, probably the only interesting
result is the one related to HDL-C, hardly modifiable by
other treatment approaches.55
In obese subjects, a more marked decrease in triglycer-
ides should be observed, related to the decrease in body
weight.56 In elderly, however, physical exercise seems
not to be related to an improvement in lipid profiles.57
Probably in this category of subjects lipid profiles could
be mildly but significantly improved by techniques like
Tai-chi-chuan (Taijiquan).58
As regards qualitative parameters, physical activity
improves the shape of LDLs, increasing the number of
large buoyant less atherogenic molecules compared with
the more atherogenic small dense ones.59 However, the
effect of diet on this parameter seems yet to be more
important.60 On the other hand, physical exercise, espe-
cially if intensive, could increase the oxidative stress of
LDLs.61
Overall, diet is more effective than physical exercise in
improving plasma lipid levels, even if physical exercise
can mildly improve the diet efficacy, and has definitely a
large number of positive effects on global cardiovascular
risk.62
Finally, statins and exercise combination therapy is more
effective than statin monotherapy in terms of insulin
sensitivity, inflammation and exercise capacity.63
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Effects of physical activity on blood pressure
The benefits of physical activity on hypertension
have been extensively reported. Hypertension has a
close relationship with endothelial dysfunction and phys-
ical activity is one of several therapeutic strategies
for lowering BP.64 It has been shown that exercise
itself promotes an improvement of the redox state and
more generally we could say that exercise has direct effects
on the vascular wall improving endothelial function via a
‘vascular condition effect’.65,66 Cornelissen et al.67 analys-
ing more than 90 randomized controlled trials, reported
that endurance, dynamic and isometric resistance training
reduce SBP and DBP; indeed more significant reductions
were described for SBP after endurance training
[3.5 mmHg (4.6–2.3), P< 0.0001], dynamic resistance
training [1.8 mmHg (3.7–0.011), P¼ 0.049], and isometric
resistance training [10.9 mmHg (14.5–7.4), P< 0.0001];
similar results were found for DBP.
Cardio50 is a project of active risk identification and
cardiovascular prevention implemented in an Italian
cohort of healthy people aged 50. After lifestyle inter-
vention, physical activity increased, whereas metabolic
syndrome, impaired fasting glucose and risky drinking
decreased. After the intervention, an early reduction in
BP and some improvements in lifestyle were observed.
This project is coherent with modern strategies based on
multifactorial actions.68
For this reason current guidelines recommended aerobic
exercises for lowering BP and is widely reported that BP
reduction decrease CHD risk by 5%, stroke by 8% and
all-cause mortality by 4%.67,69
Role of physical activity and urate-lowering
drugs on blood pressure control
Uric acid is the final product of purine catabolism and is
formed from xanthines and hypoxanthines by the action
of the xanthine oxidase, an enzyme expressed in the liver.
In normal conditions serum levels of uric acid (SUA) are
less than 6 mg/dl in women and 7 mg/dl in men, due to a
complex homeostatic regulation mainly involving the
kidney transport systems.70 Hyperuricemia might result
from either an overproduction and/or a reduced uric acid
renal excretion, thus explaining the large number of
factors able to affect SUA levels including age, sex, renal
function, the rate of cellular turnover and exogenous/
dietary factors, such as purine intake, fructose intake and
alcohol consumption.71 Recent epidemiological data
have reported an increasing trend in the prevalence
and incidence of hyperuricemia in the general popula-
tion.71–74 Meta-analysis and population-based studies
showed that hyperuricemia is frequently associated with
atherosclerotic CVD, and that hyperuricemia is an inde-
pendent risk factor for the development of metabolic
syndrome and hypertension.72–76 Experimental studies
on chronic hyperuricemia also have suggested that ele-
vated SUA may have an independent modulatory or
causal role in the development of insulin resistance,
which is well established to play a fundamental role in
the pathogenesis of all the conditions included in the
definition of metabolic syndrome (hypertension, dyslipi-
demia and impaired glucose homeostasis). Hyperurice-
mia seems to be a determinant of tissue insulin resistance,
mainly affecting insulin clearance and its signalling path-
ways.77,78 Other than by insulin resistance, how high SUA
could directly cause hypertension is still unclear, but a
progressive renal injury and arterial stiffness, via crystal
and crystal-independent mechanisms has been proposed.
Both mechanisms eventually lead to a pro-oxidative state
and inflammation that cause arteriolosclerosis and ath-
erosclerosis. It has also been demonstrated that elevated
SUA levels may trigger the renin–angiotensin system,
directly inhibiting the nitroxide synthesis in the juxta-
glomerular apparatus, as in an indirect way, stimulating
the proliferation of smooth muscle cells of the afferent
arteriole wall with a consequent reduction of renal per-
fusion.79
Once it is assumed that high SUA is an independent risk
factor and a possible cofactor for the development of
hypertension, the question arises whether hyperuricemia
has a role in BP control. This issue is relevant to under-
standing whether elevated SUA levels may impair the
efficacy of BP-lowering therapy, and/or urate-lowering
therapy should be associated with antihypertensive drugs
in these cases. The possible role of SUA in altering the
efficacy of antihypertensive treatment was studied in a
cohort of 2191 subjects enrolled in a survey.80 SUA levels
were significantly higher in untreated hypertensive and
uncontrolled hypertensive patients when compared with
normotensive subjects and controlled hypertensive
patients. Worse BP control was associated with SUA
levels, but not with age, BMI, or estimated glomerular
filtration rate. These findings showed that high SUA
levels could be associated with inadequate BP control
in subjects treated with antihypertensive drugs, and
subjects with both uncontrolled BP and relatively high
SUA levels also had significantly increased arterial stiff-
ness, measured by pulse wave velocity, a factor that could
impair BP control during treatment.81 Furthermore, some
experimental and clinical studies demonstrated that low-
ering serum uric acid levels with xanthine oxidase inhi-
bitors significantly improves SBP and DBP and renal
function, accumulating strength and support for the role
of hyperuricemia in CVD.82–84
Considering the just mentioned close correlation
between hyperuricemia and insulin resistance, and the
well documented favourable effect of lifestyle measures
for the prevention and treatment of cardiovascular risk
factors, a recent trial showed a positive effect of regular
physical activity on the SUA-hypertension relationship,
pointing to the role of plasma renin activity (PRA) as a
possible mediator for this association. PRA in the study
was significantly lower in physically active participants
6 Journal of Cardiovascular Medicine 2019, Vol 00 No 00
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compared with their sedentary counterparts. This effect
on RAS activity could prevent one of the mechanisms
whereby hyperuricemia induces BP elevation. Another
mechanism by which exercise may counteract the nega-
tive effects of high SUA on BP is improved insulin
sensitivity. The lower BMI and better metabolic profile
shown by active participants compared with their seden-
tary counterparts attest to a greater insulin sensitivity in
the former. The beneficial effect of training on BP via its
action on sympathetic activity and on other factors such as
improvement of endothelial function and reduction of
oxidative stress can have played a role in preventing
hypertension development in the active participants.85
Conclusion
In conclusion, due to the several positive effects of
physical activity on cardiovascular risk factors, active
action is required.
The WHO in their recent program document named
‘Global action plan on physical activity 2018–2030: more
active people for a healthier world’ suggested two
actions.86 The first is ‘Implement and strengthen systems
of patient assessment and counselling on increasing
physical activity and reducing sedentary behaviour, by
appropriately trained health, community and social care
providers, as appropriate, in primary and secondary
healthcare and social services, as part of universal health-
care’. The second aims to ‘Enhance the provision of, and
opportunities for, appropriately tailored programmes and
services aimed at increasing physical activity and reduc-
ing sedentary behaviour’.
The very recent ACC/AHA Guideline on the Primary
Prevention of CVD underlines that ‘Physical activity
assessment and counselling in the healthcare setting have
important complementary roles in promoting increased
physical activity’.87
The Italian Society of Cardiology and the Italian Society
of Sports Cardiology are working together to improve the
prescription of organized physical activity in patients
with CVD and/or cardiovascular risk factors and to pro-
duce new guidelines with specific information on orga-
nized physical activity.
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